Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avicanna Inc (OP:AVCNF)

0.1085 +0.0034 (+3.24%)
Streaming Delayed Price Updated: 3:51 PM EDT, Apr 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avicanna Inc

< Previous 1 2 3 4 5 Next >
News headline image
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
World's Largest Tobacco Company Is Investing In Medical Cannabis: Here's What To Know ↗
Philip Morris is expanding its medical cannabis strategy via Aurora and Avicanna. What it means for the future of Big Tobacco in the cannabinoid space. 
Via Benzinga
Topics Cannabis
News headline image
This Week In Cannabis: Carmelo's NY Launch, Federal Reform, Cancer Study, Avicanna's Growth, Tilray's Split, DeSantis Fallout, Slovenia's Big Move And More ↗
Cannabis news this week: Congress revives cannabis reform, Slovenia leads Europe, Tyson takes charge and science backs cannabis for cancer care. 
Via Benzinga
Topics Cannabis
News headline image
Why Cannabis-Focused Biopharma Co. Avicanna Traded Up 26%+ Today ↗
Shares of Avicanna Inc. 
Via Benzinga
News headline image
The Week In Cannabis: Delays, Decrees And Deals Reshape The Global Playbook ↗
Cannabis news of the week: Germany holds CanG, US delays, Chile bill; Italy hemp ban; SNDL expands, Tilray cuts outlook, US sales forecast –$21 B. 
Via Benzinga
Topics Cannabis
News headline image
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Sciences Investor Forum Agenda Announced for March 13th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
This Week In Cannabis: Rescheduling Delays, The DEA, Biden's Clemency, Philip Morris' New Bet And More ↗
Cannabis news: DEA delays reform hearings, Florida renews legalization push and global markets expand. 
Via Benzinga
Topics Cannabis
News headline image
Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets ↗
 
Via Benzinga
News headline image
Cannabis Flower Sales In Colombia And The Small Producer Protection Myth: Ex-Official Says Most Companies Qualify ↗
Colombia's cannabis decree allows dry flower sales, but ex-official claims it won't just protect small producers—most companies may qualify. 
Via Benzinga
Topics Cannabis
News headline image
CBD's Toxicity Concerns: Could Europe Ban Cannabidiol In Cosmetics? ↗
CBD could be deemed toxic for reproduction, which would then lead to its prohibition in cosmetic products across Europe. 
Via Benzinga
News headline image
Avicanna Secures Nearly $2M In Private Placement Deal Amid US Patent Win For Cannabinoid Topical Formula ↗
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Thursday that it has closed a non-brokered private placement offering of its 6,620,692 ‎‎units at $0.30 per unit for aggregate gross... 
Via Benzinga
Topics Intellectual Property
News headline image
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation ↗
Avicanna secures a U.S. patent for its innovative deep penetrating topical cannabinoid composition for treating pain and inflammation. 
Via Benzinga
Topics Intellectual Property
News headline image
Avicanna's CBG Products Reach 19 Countries: Denmark Joins Global Expansion ↗
Avicanna Inc. (OTC: AVCNF) biopharmaceutical company announced Thursday the successful export of its Aureus-branded cannabigerol (CBG) products to Denmark. 
Via Benzinga
News headline image
Avicanna Q2 Revenue Improves 85% YoY, Cannabis Company Touts Two Successful Trials On Drug Candidates ↗
 
Via Benzinga
Topics Cannabis
News headline image
Latest Cannabis Hires And Board Changes, Here's What You Need To Know ↗
Cannabis ancillary company EnWave Corporation (TSX-V: ENW) (FSE: E4U) announced on Thursday that it had tapped Danna Dunnage as its new vice president of global sales and business development. Dunnage... 
Via Benzinga
Topics Cannabis
News headline image
Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country ↗
Cannabinoid-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Thursday that through its majority-owned subsidiary Santa Marta Golden Hemp the company... 
Via Benzinga
Topics Cannabis
News headline image
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
CBD-Focused Avicanna Reports First-Ever Adjusted EBITDA Positive Quarter, 451% YoY Spike In Q1 Record Revenue ↗
Cannabis-focused biopharmaceutical company Avicanna Inc. announced on Tuesday financial results for the first quarter of fiscal 2024.CEO Aras Azadian called it its "best quarter." In addition to being... 
Via Benzinga
News headline image
CBD Helps With This Rare Blistering Skin Disorder, New Study From Avicanna Shows Promising Results In Epidermolysis Bullosa Treatment ↗
There is no cure for a rare blistering skin disorder called Epidermolysis Bullosa (EB). But, treatments to help alleviate and control the symptoms do exist. The growing body of research suggests... 
Via Benzinga
Topics Cannabis
News headline image
Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY ↗
Cannabinoids-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) reported on Tuesday year-end 2023 results and audited financial statements. The Canadian company... 
Via Benzinga
Topics Cannabis
News headline image
This Company Is Bringing Medical Marijuana Telehealth To Over Half The U.S. ↗
MMJ.com, a telehealth platform providing access to medical marijuana, has expanded its services to 26 states. This expansion allows patients to consult state-certified doctors online for medical... 
Via Benzinga
Topics Cannabis
News headline image
Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global ↗
Clever Leaves Holdings Inc. 
Via Benzinga
Topics Cannabis
News headline image
CBD-Focused Avicanna Taps Into European Market Via Exclusive Pharma Supply Deal ↗
Canadian cannabinoid-based biopharmaceutical firm Avicanna will supply two proprietary topical products to an unnamed multinational pharmaceutical firm in six European countries in 2024. The deal will... 
Via Benzinga
News headline image
CBD-Focused Avicanna Announces Funding Boost For Research And Development ↗
Cannabinoid-based biopharmaceutical company Avicanna Inc. 
Via Benzinga
News headline image
Avicanna Inc.: Medical Marijuana Sales Reach Record 713% YoY Growth In Q3, Introduces New Platform ↗
Avicanna Inc. (OTCQX: AVCNF) a biopharmaceutical company specializing in proprietary cannabinoid-based products, announced Q3 2023 results late Tuesday, highlighted by the successful acquisiti 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Stock Gainers And Losers From August 25, 2023 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Marijuana Stock Movers For August 23, 2023 ↗
 
Via Benzinga
Topics Cannabis
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.